European Journal of Clinical Investigation

Papers
(The H4-Index of European Journal of Clinical Investigation is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease283
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis262
Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures242
Bloodstream infections in critically ill patients with COVID‐19191
Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis166
Features of severe COVID‐19: A systematic review and meta‐analysis132
Assessing mandatory stay‐at‐home and business closure effects on the spread of COVID‐19128
Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic123
SARS‐CoV‐2 re‐infection risk in Austria122
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics92
Prognostic implications of neutrophil‐lymphocyte ratio in COVID‐1983
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations81
The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections64
Estimate false‐negative RT‐PCR rates for SARS‐CoV‐2. A systematic review and meta‐analysis62
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship61
Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID‐19 patients59
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis50
Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study47
COVID‐19 re‐infection46
COVID‐19 Susceptibility in chronic obstructive pulmonary disease44
The De Ritis ratio as prognostic biomarker of in‐hospital mortality in COVID‐19 patients44
PCSK9 and atherosclerosis: Looking beyond LDL regulation44
The end of the COVID‐19 pandemic42
Histopathology and genetic susceptibility in COVID‐19 pneumonia42
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID‐1941
Platelet‐to‐lymphocyte ratio and prognosis in STEMI: A meta‐analysis40
COVID‐19: Focus on the lungs but do not forget the gastrointestinal tract39
High‐dose methylprednisolone in nonintubated patients with severe COVID‐19 pneumonia39
Circ_0007142 downregulates miR‐874‐3p‐mediated GDPD5 on colorectal cancer cells38
Reorganization of a large academic hospital to face COVID‐19 outbreak: The model of Parma, Emilia‐Romagna region, Italy33
Cardiac troponin and COVID‐19 severity: Results from BIOCOVID study33
Diagnostic accuracy of infrared thermal imaging for detecting COVID‐19 infection in minimally symptomatic patients33
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches33
0.030846118927002